IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Vijaypd Ceutical IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Smart Horizon Capital Advisors Private is the merchant banker of Vijaypd Ceutical IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd December 2024.
Vijaypd Ceutical IPO posted revenues of Rs 111.98 crores and PAT of Rs 6.10 crores in FY25 on annualised basis.Financial results of Vijaypd Ceutical IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Vijaypd Ceutical IPO PAT Margin is 5.43%, ROCE (Return on Capital Employed) is 11.47% as per latest financial. The below table shows Vijaypd Ceutical IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Vijaypd Ceutical IPO is Rs [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Vijaypd Ceutical IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Vijaypd Ceutical IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Vijaypd Ceutical IPO is ₹[●] Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Vijaypd Ceutical IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Vijaypd Ceutical IPO reported revenue of ₹111.98 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Vijaypd Ceutical IPO provide insights into sales growth, market demand, and business scalability.
Vijaypd Ceutical recorded an EBITDA of ₹ 11.36 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Vijaypd Ceutical Profit After Tax (PAT) is ₹6.08 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 111.96 Cr.
EBITDA Margin:
10.15
%
Net Worth: ₹ 30.42 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Vijaypd Ceutical operates in Pharmaceutical and . The Issue is listed on NSE EMERGE in Apr, 2025. Vijaypd Ceutical IPO size was with Issue price of .
Merchant Banker(s) of Vijaypd Ceutical IPO: Smart Horizon Capital Advisors Private Limited
Vijaypd Ceutical IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Vijaypd Ceutical IPO listed at a listing price of against the offer price of .
The current market price of Vijaypd Ceutical is .
Why Us?
